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ABSTRACT Sunburn is a commonly occurring acute
inflammatory process, with dermal vasodilatation and
leukocyte infiltration as central features. Ultraviolet
(UV) B-induced hydrolysis of membrane phospholipids
releases polyunsaturated fatty acids, and their subse-
quent metabolism by cyclooxygenases (COXs) and li-
poxygenases (LOXs) may produce potent eicosanoid
mediators modulating different stages of the inflamma-
tion. Our objective was to identify candidate eico-
sanoids formed during the sunburn reaction in relation
to its clinical and histological course. We exposed skin
of healthy humans (n32) to UVB and, for 72 h,
examined expression of proinflammatory and anti-
inflammatory eicosanoids using LC/ESI-MS/MS, and
examined immunohistochemical expression of COX-2,
12-LOX, 15-LOX, and leukocyte markers, while quanti-
fying clinical erythema. We show that vasodilatory
prostaglandins (PGs) PGE2, PGF2, and PGE3 accom-
pany the erythema in the first 24–48 h, associated with
increased COX-2 expression at 24 h. Novel, potent
leukocyte chemoattractants 11-, 12-, and 8-monohy-
droxy-eicosatetraenoic acid (HETE) are elevated from
4 to 72 h, in association with peak dermal neutrophil
influx at 24 h, and increased dermal CD3 lymphocytes
and 12- and 15-LOX expression from 24 to 72 h.
Anti-inflammatory metabolite 15-HETE shows later ex-
pression, peaking at 72 h. Sunburn is characterized by
overlapping sequential profiles of increases in COX prod-
ucts followed by LOX products that may regulate subse-
quent events and ultimately its resolution.—Rhodes, L. E.,
Gledhill, K., Masoodi, M., Haylett, A. K., Brownrigg, M.,
Thody, A. J., Tobin, D. J., Nicolaou, A. The sunburn
response in human skin is characterized by sequential
eicosanoid profiles that may mediate its early and late
phases. FASEB J. 23, 3947–3956 (2009). www.fasebj.org
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Acute ultraviolet (UV) B exposure of the skin
produces sunburn, an inflammatory response evident
visually as erythema and characterized histologically by
a mixed dermal neutrophilic and lymphocytic infil-
trate. Peak vasodilatation is reached at 24 h (1) and
neutrophil infiltration at 24–48 h (2–4), while dermal
infiltration by T lymphocytes may exhibit a later time
course (5). Whereas prostaglandin (PG) E2 and nitric
oxide have roles in the vasodilatation (1, 6, 7), and
cytokines, including interleukin-8, contribute to the
leukocyte infiltration (3), the mediation of induction
and resolution of the sunburn response is incompletely
understood and is anticipated to involve a wider range
of eicosanoids.
Skin displays highly active metabolism of polyunsat-
urated fatty acids (PUFAs), resulting in the production
of eicosanoids that modulate physiological processes at
low concentrations and elicit inflammatory reactions at
higher levels (8). Activation of membrane phospho-
lipase A2 by UVB effects release of fatty acids, notably
the  (n)-6 PUFA arachidonic acid (AA; 20:4n-6), and
potentially the n-3 PUFA eicosapentaenoic acid (EPA;
20:5n-3), which has also been detected in human skin
(9) (Scheme 1). Subsequently, these PUFAs may be
metabolized by cyclooxygenases (COXs) and lipoxyge-
nases (LOXs) to a wide range of eicosanoids and other
lipid mediators. High COX-2, 12-LOX, and 15-LOX
activity is reported in epidermal cells, and infiltrating
neutrophils may possess 5-LOX activity (8, 10). Consid-
erable species differences are reported for LOX expres-
sion (11), and additional fatty acid metabolism by
cytochrome P-450 and nonenzymatic oxidation may
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contribute to production of a wide diversity of metab-
olites (12).
Following UVB exposure, COX-2 expression was
found to be elevated in human skin when assessed at
the single time point of 24 h (13). Recently, UVB was
reported to modulate 12-LOX and 15-LOX expression
in a keratinocyte cell line, with reciprocal regulation of
these LOXs, suppressing 12-LOX, while up-regulating
15-LOX (14). However, there is scant information
concerning the effects of UVB on LOX expression in
human skin. Furthermore, through technical limita-
tions, only a restricted range of UV-induced skin eico-
sanoids have been examined to date; consequently,
detailed characterization of eicosanoids possessing
properties that potentially mediate the course of hu-
man sunburn is lacking. Recently developed lipidomic
assays based on electrospray ionization-liquid chroma-
tography-tandem mass spectrometry (ESI-LC-MS-MS)
now permit assessment of a wide range of metabolites
(15, 16).
We examined the expression and temporal relation-
ship of candidate eicosanoids that may mediate both
the early and later phases of vasodilatation and leuko-
cyte infiltration, and potentially also the resolution
phase, of the sunburn response, in 32 healthy humans.
The clinical (skin erythema) and histological (leuko-
cyte infiltration) response was followed for 72 h, with
detailed characterization of cutaneous eicosanoid ex-
pression, and direct assessment of UVB regulation of
COX-2, 12-LOX, and 15-LOX expression over this
period. We specifically examined for vasodilatory pro-
stanoids derived through COX metabolism of both -6
and -3 PUFAs (i.e., AA and EPA), and for a range of
hydroxyeicosatetraenoic acids (HETEs) expressing che-
moattractant properties for neutrophils and lympho-
cytes (17, 18) or anti-inflammatory properties (11).
MATERIALS AND METHODS
Subjects
The study group comprised 32 healthy white Caucasian
subjects of mean age 40 yr (range 19 to 58 yr; 20 female) and
sun-reactive skin types I-IV. Exclusions from the study were
sunbathing or sunbed use in the prior 3 mo, photosensitizing
or anti-inflammatory medication, and history of skin cancer
or photosensitivity disorders. The study conformed to the
Declaration of Helsinki 2000, North Manchester Research
Ethics Committee approval was obtained, and all volunteers
gave written informed consent.
UV irradiation
The UV radiation (UVR) source used was a fluorescent UVB
lamp, (Waldmann UV6; emission 290–400 nm, peak 313 nm;
Herbert Waldmann GmbH, Villingen-Schwenningen, Ger-
many). Minimal erythema dose (MED) testing was performed
by applying a geometric series of UV doses ranging from 13 to
128 mJ/cm2 of erythemally weighted UVR in a horizontal row
to the upper buttock skin. The MED was assessed at 24 h, and
defined as the lowest dose of UVB that resulted in detectable
erythema. Volunteers were given MED-related doses in order
to standardize the UVB challenge according to individual
erythemal sensitivity. Three sites on the buttock skin were
irradiated with 4 times the individual’s MED of UVB, a dose
sufficient to produce a well-defined clinical and histological
inflammatory response. These sites were utilized for erythema
time course determination and suction blister fluid sampling
(n22 subjects) or skin-punch biopsy sampling for immuno-
histochemical investigations (n10 subjects).
Assessment of erythemal responses
Erythemal responses were quantified using a reflectance
instrument (Diastron, Andover, UK), which gives an ery-
thema index related to the blood content of the superficial
dermis. Triplicate measurements were taken from the test
sites and adjacent unirradiated skin, and the means were
calculated.
Suction blister sampling
Suction blister fluid was sampled from unirradiated skin and
from skin at 4, 18, 24, 48, and 72 h following a dose of UVB
(4MED). Each volunteer provided a sample from an unir-
radiated site on one buttock, and samples from 3 irradiated
sites on the contralateral buttock, each site being sampled on
one occasion. Half of the volunteers were sampled at base-
line, 4, 18, and 24 h, and the others at baseline, 24, 48, and
72 h, with erythema readings taken at the same time points.
Suction blister cups with 1-cm central aperture were applied
with a vacuum pressure of 250 mm Hg, as described previ-
ously (19). When blisters had formed (after 90 min), the
fluid was aspirated with a 23-gauge needle, snap-frozen, and
stored at 80°C until analysis.
Lipidomic analysis
Lipidomic analyses were performed as described by Masoodi
et al. (15, 16). Briefly, blister fluid samples (typical volumes
50–200 l) were diluted with methanol-water (15% wt/wt) to
a final volume of 3 ml. Internal standards (40 ng PGB2-d4 and
80 ng 12-HETE-d8; Cayman Chemicals, Ann Arbor, MI, USA)
were added to each sample. The resultant solutions were
acidified to pH 3 and immediately applied to preconditioned
solid-phase extraction cartridges (C18-E; Phenomenex,
Macclesfield, UK) to extract the lipid mediators. Chromato-
graphic analysis was performed on a C18 column (Luna 5
m; Phenomenex) using a Waters Alliance 2695 HPLC pump
coupled to an ESI triple-quadrupole Quattro Ultima mass
spectrometer (Waters, Elstree, UK). Instrument control and
data acquisition were performed using MassLynx 4.0 software
(Waters). The following multiple reaction monitoring (MRM)
transitions were used for the assay of prostanoids and hydroxy
fatty acids: PGE2, m/z 351  271; 13,14-dihydro-15-keto PGE2,
m/z 351 333, 349 113; PGF2, m/z 353 193; 13,14-dihydro-
15-keto PGF2, m/z 353  113; PGE1, m/z 353  317; 13,14-
dihydro-15-keto-PGE1, m/z 353  335; PGE3, m/z 349  269;
LTB4, m/z 335 195; 11-HETE, m/z 319  167; 12-HETE, m/z
319  179; 8-HETE, m/z 319  155; and 15-HETE, m/z 319 
175. Results are expressed as picograms of metabolite per
milligram of protein, based on calibration lines constructed
with commercially available eicosanoid standards (Cayman
Chemicals). Protein content was estimated using the Bio-Rad
protein assay kit with BSA as standard (Bio-Rad, Hemel
Hempstead, UK).
Immunohistochemical assessment
Skin-punch biopsies (5-mm diameter) were sampled from
unirradiated skin and from skin at 4, 24, and 72 h following
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exposure to 4  MED of UVB (see above). Biopsies were
snap-frozen and stored at 80°C prior to immunohistochem-
ical analysis. Frozen sections (6 m) were air-dried before
fixation in ice-cold acetone (Fisher Scientific UK, Loughbor-
ough, UK) for 10 min. Endogenous peroxidase was quenched
in hydrated tissue sections with 0.5% H2O2 (Sigma-Aldrich
Co., Gillingham, UK) before blocking with 10% goat serum
(Sigma-Aldrich) for 1 h. Primary antibody was added to the
sections at the required dilution and incubated overnight at
4°C. The primary antibodies used in this study were as follows.
Neutrophil elastase: MAB 1056, dilution 1:70 (Chemicon
Europe, Chandlers Ford, UK); CD3	: NCL-CD3, dilution 1:40
(NovoCastra Reagents, Leica Biosystems, Newcastle on Tyne,
UK); 12-LOX: ab23678, dilution 1:200 (Abcam plc, Cam-
bridge, UK); 15-LOX: 10004454, dilution 1:100 (Cayman
Chemical, Boldon, UK); COX-2: ALX-210-712-1, dilution
1:100 (Alexis Biochemicals, Lausen, Switzerland). After wash-
ing in PBS, skin sections were incubated with biotinylated
anti-mouse secondary antibody (DakoCytomation, Ely, UK)
for 30 min, washed in PBS, and incubated with streptavidin
peroxidase (DakoCytomation) for 30 min. Sections were
developed using aminoethylcarbazole chromogen (Vector
Laboratories, Peterborough, UK) for 5–10 min, washed in
distilled water, lightly counterstained in Meyers hematox-
ylin (Sigma-Aldrich), and mounted in glycergel mounting
medium (DakoCytomation). The sections were assessed
using a Nikon Eclipse 80i microscope at 200 view and a
Nikon Digital Sight DS-U1 camera (Nikon UK, Kingston on
Thames, UK).
Quantification of immunohistochemical staining
Slides were masked prior to assessment. Neutrophils and
CD3	 cells were counted in 3 randomly selected epidermal
and dermal high-power fields (hpf) at 400. This technique
was employed for each individual at each of 4 time points.
COX and LOX staining was quantified in terms of relative
staining intensity, according to the following scoring system:
0  no staining, 1  weak staining, 2  moderate staining,
3  intense staining. 12-LOX, 15-LOX, and COX-2 were
graded in epidermal and dermal hpf at200. Assessment was
made for each individual at each of the 4 time points.
Statistical analysis
Data were analyzed with StatsDirect (Stats Direct, Altrincham,
UK). Nonparametric data were analyzed using the Kruskal-
Wallis test with adjustment for multiple comparisons, and
parametric data were analyzed using 1-way ANOVA with
Bonferroni correction. All results are compared with levels in
non-UV-exposed tissue unless otherwise stated. Statistical
significance was accepted at the P 
 0.05 level.
RESULTS
UVB-erythema time course
Erythema was clinically visible at 4 h following UVB
exposure, with a significant elevation of the erythema
index at this time point, rising from a mean  se
baseline value of 39.9  3.6 to 97.2  13.4 at 4 h
(P
0.001). The erythema index peaked at 18–24 h
after UVB exposure (160.86.3 and 171.13.6, respec-
tively) and remained elevated at 72 h (156.66.4,
P
0.001) (Fig. 1).
Effect of UVB on COX-mediated eicosanoid
production
PGE2 and metabolite
Analysis of suction blister fluid from unexposed skin
revealed baseline levels of PGE2 and its inactive metab-
olite 13,14-dihydro-15-keto PGE2 of 26.83  3.1 and
31.7  2.63 pg/mg protein, respectively. Following
UVB, PGE2 levels were above the baseline level at all
time points 4–72 h, with statistically significant eleva-
tion at 18 and 24 h (32.815.13 and 38.053.95
pg/mg protein, respectively; P0.02) (Fig. 2A), while
13,14-dihydro-5-keto PGE2 was significantly elevated at
72 h (50.456.86 pg/mg protein; P0.02) (Fig. 2B).
PGF2 and metabolite
Baseline levels of PGF2 and 13,14-dihydro-15-keto
PGF2 were 30.47  3.53 and 0.81  0.81 pg/mg
protein, respectively. Prostaglandin F2 also showed a
significant rise at 18 h (44.846.66 pg/mg protein;
P0.03), but in contrast to PGE2, it returned to
baseline levels by 24 h (30.12.57 pg/mg protein)
(Fig. 2C). However, the inactive PGF2 metabolite
13,14-dihydro-15-keto PGF2, was significantly ele-
vated at 48 and 72 h (17.624.39 pg/mg protein,
P0.003 and 13.655.02 pg/mg protein, P0.049,
respectively) (Fig. 2D).
PGE1 and metabolite
Baseline levels of PGE1 and 13,14-dihydro-15-keto PGE1
were 17.14  3.58 and 7.60  2.18 pg/mg protein,
respectively. Following UVB, the same overall trend was
noted as for the above prostanoids. Although PGE1
Figure 1. Time course of sunburn erythema in human skin.
Buttock skin of healthy human volunteers (n22) was ex-
posed to a UVB dose equivalent to 4 each volunteer’s
sunburn threshold (4MED). Erythemal response was quan-
tified using a reflectance technique, giving an erythema index
(EI) proportional to the blood content of the superficial
dermis. Results are expressed as mean  se EI in unexposed
skin and in skin at 4, 18, 24, 48, and 72 h after UVB exposure.
*P 
 0.05, **P
0.001 vs. unexposed skin.
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concentration was not significantly elevated over base-
line levels (Fig. 2E), its inactive metabolite 13,14-dihy-
dro-15 keto-PGE1 was significantly elevated at 48 and
72 h postexposure (17.863.58 pg/mg protein, P
0.02, and 25.333.55 pg/mg protein, P0.0001, re-
spectively) (Fig. 2F).
PGE3
Baseline level of this -3-PUFA-derived prostanoid was
5.60  2.03 pg/mg protein. Following UVB, PGE3
increased by 4 h (12.063.73 pg/mg protein) and still
appeared elevated above baseline at 72 h (10.53.93
pg/mg protein), with significant elevations found at 18,
24, and 48 h (16.653.66 pg/mg protein, P0.04;
12.761.81 pg/mg protein, P0.04; and 14.082.85
pg/mg protein, P0.03, respectively) (Fig. 2G).
Effect of UVB on LOX-mediated eicosanoid
production
8-HETE
Baseline level was 0.64 0.64 pg/mg protein; following
UVB, 8-HETE became significantly elevated at 24 h
(13.783.69 pg/mg protein, P0.003) and showed a
progressive rise to 72 h (316.11 pg/mg protein,
P
0.0001) (Fig. 3A).
11-HETE
Baseline level was 1.17  0.7 pg/mg protein; 11-HETE
was significantly elevated at the first time point of
assessment following UVB, i.e., 4 h (5.541.94 pg/mg
protein, P0.02), peaked at 18 h (10.682.45 pg/mg
protein, P
0.0001), and remained elevated to 72 h
(10.543.78 pg/mg protein, P0.0004) (Fig. 3B).
12-HETE
Baseline level was 20.25  9.82 pg/mg protein. Follow-
ing UVB, 12-HETE became significantly elevated at
18 h (105.8534.64 pg/mg protein, P0.007), with a
progressive rise at subsequent time points and peak
level at 72 h (251.5160.85 pg/mg protein, P
0.0001)
(Fig. 3C).
15-HETE
Baseline value of 15-HETE was 2.16  1.37 pg/mg
protein. Following UVB, 15-HETE showed significant
Figure 2. Levels of -6 and -3 PUFA-derived prostanoids and their metabo-
lites in cutaneous blister fluid during sunburn response. Panels show PGE2
(A), 13,14-dihydro-15-keto PGE2 (B), PGF2 (C), 13,14-dihydro-15-keto PGF2
(D), PGE1 (E), 13,14-dihydro-15-keto PGE1 (F), and PGE3 (G). Buttock skin of
healthy volunteers (n22) was exposed to 4  MED of UVB. Blisters were
formed on UVB-exposed and unexposed skin, using suction cups and a
vacuum pressure of 250 mmHg. Blister fluid samples were semipurified by
solid phase extraction, followed by analysis by ESI/LC-MS/MS. Eicosanoids
were identified by their m/z value and mass spectra, and quantitation was
performed using multiple reaction monitoring-based assays. Results are
expressed as mean  se mediator (pg/mg protein) in unexposed skin and at
4, 18, 24, 48, and 72 h after UVB exposure. *P 
 0.05, **P 
 0.01, ***P 

0.001 vs. unexposed levels.
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elevation by 24 h (13.583.26 pg/mg protein,
P0.007), and was still rising at the last (72 h) time
point (25.88 pg/mg protein, P0.002) (Fig. 3D).
LTB4
LTB4 was undetectable at baseline and at all time
points following UVB.
Cutaneous leukocytic infiltration following UVB
Neutrophils
Neutrophil polymorphs, identified by their staining
with antineutrophil elastase antibody, were present in
unirradiated epidermal and dermal samples (0.97
0.65 and 3.071.45 cells/hpf, respectively) (Fig. 4). Der-
mal neutrophil levels peaked at 24 h after UV exposure
(mean 8.6/hpf; P0.03) returning to baseline levels by
72 h. The number of epidermal neutrophils was not
significantly different from baseline levels.
CD3	 cells
Baseline levels of CD3	 lymphocytes were 0.53  0.3
and 10.8  1.66 cells/hpf in epidermis and dermis,
respectively (Fig. 5). The number of CD3	-positive cells
was significantly elevated above baseline at 24 h after
UVB exposure (mean 22.635.11 cells per hpf; P
0.02), and remained significantly elevated at 72 h after
UVB (mean 24.72.97 cells/hpf; P
0.001 vs. base-
line). No significant changes were seen in epidermal
levels of CD3	 cells.
Cutaneous expression of COX-2, 12-LOX, and 15-
LOX following UVB
COX-2
Baseline staining intensity of COX-2 was 0.14  0.14
and 0.71  0.29 in the epidermis and dermis, respec-
tively (Fig. 6). A significant increase in COX-2 staining
intensity was observed at 24 h after UVB exposure, for
both dermis and epidermis (1.430.37 and 1.290.36;
P0.04 and P0.03, respectively).
12-LOX
Relative baseline staining intensity of 12-LOX was
0.14  0.14 and 1.43  0.3 for the epidermis and
dermis, respectively (Fig. 7). This was significantly
elevated in the dermis at 4 h after UVB exposure (mean
2.290.29; P0.02), and in the epidermis at 24 and
72 h after UVB (mean 10.22 and 1.290.36; P0.02
and P0.005, respectively).
15-LOX
Relative baseline staining intensity for 15-LOX was
0.75  0.25 and 1.13  0.23 in the epidermis and
dermis, respectively (Fig. 8). In the dermis a significant
increase relative to baseline was seen at 24 h after UVB
exposure (2.750.16 P0.001). The epidermis also
showed a significant increase in staining intensity at
24 h after UVB (20.33; P0.01), and this remained
significantly elevated at 72 h after UVB (1.630.18;
P0.02).
DISCUSSION
This study provides for the first time a detailed charac-
terization of the candidate eicosanoid mediators of the
Figure 3. Levels of 8-, 11-, 12-, and 15-HETE in cutaneous blister fluid during
sunburn response. Panels show 8-HETE (A), 11-HETE (B), 12-HETE (C), and
15-HETE (D). Blister fluid samples from unexposed skin and 4  MED of
UVB-exposed skin were collected and analyzed (n22 subjects; see Fig. 2).
Results are expressed as mean  se mediator (pg/mg protein) in unexposed
skin and at 4, 18, 24, 48, and 72 h after UV exposure. *P 
 0.05, **P 
 0.01,
***P 
 0.001 vs. unexposed levels.
3951EICOSANOIDS IN THE SUNBURN RESPONSE
sunburn response up to 72 h, identifying bioactive lipid
mediators that may be responsible for the principal
clinical and histological components of vasodilatation
and leukocyte infiltration (Scheme 1). Our data sup-
port that a range of prostanoids, including n-3 PUFA-
derived PGE3, in addition to n-6 PUFA-derived PGE2,
are produced during the sunburn reaction. They fur-
ther suggest that the potent chemoattractants 8-HETE,
11-HETE, and 12-HETE may contribute to the leuko-
cyte influx, while the anti-inflammatory metabolite
15-HETE may serve to limit or aid resolution of the
inflammation. Eicosanoid-producing enzymes 12-LOX
and 15-LOX are both up-regulated, in contrast to
recent findings in a keratinocyte cell line (14). Expres-
sion of COX and LOX does not necessarily reflect
enzyme activity. However, we observe that while COX-2
shows significantly increased expression only at 24 h,
12- and 15-LOX show sustained increase in expression
at 72 h, consistent with the earlier and later peaks of
their respective prostanoid and HETE metabolites dur-
ing the sunburn response (Scheme 2).
Our results indicate that after an early increase in n-6
PUFA-derived prostaglandins PGE2, PGF2, and PGE1
following UVB exposure, these potent mediators are
enzymatically inactivated (Fig. 2), as reflected by in-
creases in their respective 13,14-dihydro-15-keto deriv-
atives. Although it is established that PGE2 contributes
Figure 5. CD3	 lymphocytic infiltrate in epidermis and
dermis during the sunburn response. Graphical presentation
of time course (A), with representative photomicrographs of
sections from unexposed skin (B) and skin at 4 h (C), 24 h
(D), and 72 h (E) after UVB exposure. Punch biopsy samples
were collected from buttock skin of healthy volunteers, and
immunohistochemical analysis was performed to determine
numbers of CD3	 cells per hpf (see Fig. 4). Results are
expressed as mean se cell count; n 10. *P
 0.05, ***P

0.001 vs. baseline.
Figure 4. Neutrophil infiltrate in epidermis and dermis
during sunburn response. Graphical presentation of time
course (A), with representative photomicrographs of sections
from unirradiated skin (B) and skin at 4 h (C), 24 h (D), and
72 h (E) after UVB exposure. Punch biopsy samples were
collected from the buttock skin of healthy volunteers prior to
and at intervals after exposure to 4  MED of UVB. Frozen
skin sections were immunohistochemically stained using an-
tineutrophil elastase monoclonal antibody. Numbers of cells
staining positive per hpf (400 original view) were counted,
using 3 fields in random epidermal/dermal interface loca-
tions for each time point. Results are expressed as mean  se
cell count; n  10. *P 
 0.05 vs. baseline.
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to UVB-induced vasodilatation in the first 24–48 h (1,
6, 20), the contribution of PGF2 to erythema produc-
tion is uncertain. Intradermal injection of PGF2, as
with PGE1 and PGE2, can produce skin erythema (21,
22), but the relevance of these findings is unclear in
view of the higher than physiological doses used; more-
over, PGF2 is described as a vasoconstrictor in some
systems (23). Whereas we did not directly detect a
significant increase in the COX-metabolized vasodila-
tor PGE1, derived from dihommogammalinolenic acid,
its inactive metabolite was significantly elevated at
48–72 h after UVB exposure, indicating the earlier
elevation of the mediator. This pattern of controlled
prostaglandin production suggests an active response
of the tissue to UVR-induced injury. Moreover, PGE2
has complex roles, contributing to tissue repair in
addition to mediating vasodilatation and inflammation
(24), and inducing COX-2, and thereby its own synthe-
sis (25), while displaying anti-inflammatory effects, in-
cluding inhibition of 5-LOX (26) and induction of
15-LOX (27–29). Thus, sunburn is a self-resolving
model of injury exhibiting preparation for its resolu-
tion through the quick deactivation of proinflamma-
tory signals and activation of repair mechanisms.
Interestingly, we found significant elevation of the
n-3 PUFA-derived PGE3, from 18 to 48 h following UV.
This mediator has not previously been reported in
human skin, although its discovery is consistent with
detection of the precursor n-3 PUFAs EPA and docosa-
hexaenoic acid (DHA) in human epidermal phospho-
Figure 7. Expression of 12-LOX in the epidermis and dermis
during the sunburn response. Graphical presentation of time
course of 12-LOX (A), with representative photomicrographs
of sections from unirradiated skin (B) and skin at 4 h (C),
24 h (D), and 72 h (E) after UVB exposure. Punch biopsy
samples were collected from buttock skin of healthy volun-
teers prior to and at intervals after exposure to 4  MED of
UVB. Immunohistochemical analysis was performed to deter-
mine relative levels of 12-LOX present in dermis and epider-
mis. Frozen sections were scored for staining intensity (200
original view; see Fig. 6). Arrows indicate 12-LOX staining.
Results are expressed as mean  se staining intensity; n  7.
*P 
 0.05; **P 
 0.01 vs. baseline.
Figure 6. Expression of COX-2 in the epidermis and dermis
during sunburn response. Graphical presentation of time
course (A), with representative photomicrographs of sections
from unexposed skin (B) and skin at 4 h (C), 24 h (D), and
72 h (E) after UVB exposure. Biopsy samples were collected
from buttock skin of healthy individuals, and immunohisto-
chemical analysis was performed to determine levels of
COX-2 expression in dermis and epidermis. Frozen sections
were scored for relative staining intensity: 0  no staining;
1  weak staining; 2  moderate staining; 3  intense
staining. Three hpf in random epidermal/dermal interface
locations were examined for each time point. Arrows indicate
COX-2 staining. Results are expressed as mean  se staining
intensity; n  8. *P 
 0.05 vs. baseline.
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lipids (9, 30). In many respects, PGE3 is believed to
possess similar functions to PGE2, but with reduced
potency (31), and thus PGE3 may contribute to the
erythema following UVB, although it may also reduce
the efficacy of PGE2 through acting as its partial ago-
nist. Although neither PGE2 nor PGE3 was significantly
elevated at 72 h, they appear not to have returned to
baseline level at this time point, and the combined
effects of the vasodilatory prostaglandins, together with
nitric oxide (1, 7), could continue to influence sun-
burn erythema at the later time point. Cyclooxygenase
and nitric oxide synthase inhibitors each reduce the
erythemal component of the sunburn response at least
to 48 h after UVB exposure (1).
During sunburn, neutrophils accumulate in the der-
mis (2, 3) where they exert proinflammatory activities,
including further release of mediators with chemoat-
tractant properties. The infiltration occurs from 4 h
after UVB onward and is consistent with our observa-
tions of the increase in a range of chemoattractant
HETE. Neither 11-HETE nor 8-HETE has to our knowl-
edge previously been reported in human skin, while
8-HETE has been detected in mouse skin (32). Their
derivation is uncertain but potentially results from a
combination of LOX, CYP450, and nonenzymatic oxi-
dation pathways (11). Because both are potent neutro-
phil chemoattractants in in vitro and experimental
models in other systems (18), they are anticipated to
make a substantial contribution to the leukocyte che-
moattraction in sunburn, particularly as there is signif-
icant elevation of 11-HETE as early as 4 h. The potent
keratinocyte-derived chemoattractant 12-HETE pro-
duces a mixed neutrophilic and mononuclear infiltrate
following intradermal injection (33) and has been
shown in vitro to be a chemoattractant for lymphocytes
in addition to neutrophils (17). While 12-HETE has
Figure 8. Expression of 15-LOX in the epidermis and dermis
following UVB irradiation. Graphical presentation of time
course of 15-LOX expression (A), with representative pho-
tomicrographs of sections from unirradiated skin (B) and
skin at 4 h (C), 24 h (D), and 72 h (E) after UVB exposure.
Punch biopsy samples were collected from buttock skin of
healthy volunteers prior to and at intervals after exposure to
4  MED of UVB. Immunohistochemical analysis was per-
formed on frozen skin sections to determine relative levels of
15-LOX in dermis and epidermis (see Fig. 6). Arrows indicate
15-LOX staining. Results are expressed as mean  se staining
intensity; n  8. *P 
 0.05, **P 
 0.01 vs. baseline.
Scheme 1. COX- and LOX-generated PUFA metabolites.
Simplified illustration to show COX- and LOX-generated
metabolites of the principal long-chain n-6 and n-3 PUFAs,
AA, and EPA, respectively, focusing on eicosanoids relevant to
the present study.
Scheme 2. Composite illustration of the principal events of
the sunburn response. Illustration shows the skin erythemal
and leukocytic responses to UVB, indicating proposed key
time points for contributions of COX- and LOX-generated
eicosanoids.
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been reported to be elevated in cutaneous inflamma-
tory states, i.e., in psoriasis (34) and contact dermatitis
(35), Black et al. (35) found 12-HETE elevated at 24 but
not 72 h after UV exposure in a study of skin blister
fluid in 6 subjects, and Grundmann et al. (36) detected
12-HETE at 3 but not 24 h in dermal microdialysate in
3 subjects. Our findings, in a larger subject group, of
higher and more sustained 12-HETE up-regulation,
contrast with these reports and support a significant
role for this 12-LOX-derived metabolite in the sunburn
response, potentially including the prolonged (to 72 h)
CD3	 cell infiltration.
The neutrophil chemoattractants LTB4, believed to
play a role in a range of skin inflammatory conditions
(37), and 5-HETE were undetectable. It is conceivable
that these mediators were present in a cellular compart-
ment inaccessible for sampling via the suction blister
method, since a slight although nonstatistically signifi-
cant UV-associated rise in 5-HETE was detected in
dermal microdialysate (36). However, LTB4 has been
detected in suction blister fluid in a range of other
skin inflammatory states (38, 39), and our data
correspond with earlier reports of lack of up-regula-
tion of LTB4 and 5-HETE following UVB exposure of
mouse skin (40, 41). UVB-up-regulated PGE2 may
inhibit 5-LOX and thereby production of the LT4
series (26), while 15-HETE may also inhibit LTB4
synthesis (42). Thus, a specific proinflammatory pro-
file of LOX metabolite expression is apparent in
sunburn, distinct from that observed in other skin
inflammatory states, providing evidence against the
supposition that “LTB4 may be a prerequisite for
emigration of leukocyte into dermis” (43).
A further novel, and intriguing, finding was the
significant UVB up-regulation of the anti-inflammatory
eicosanoid 15-HETE, exhibiting a later response with
mean levels observed to double between 48 and 72 h
and potentially rising beyond 72 h. This 15-LOX me-
tabolite has been shown to inhibit the synthesis of
proinflammatory eicosanoids PGE2 and 12-HETE in
in vitro models (14, 44) and to inhibit the activity of
12-LOX in epidermis (45) and 5-LOX in neutrophils
(44). Hence, the later elevation of this mediator could
reflect a role in the resolution of sunburn, including
limitation of the neutrophil influx. Other eicosanoids
could potentially also possess restorative roles at later
time points, including, paradoxically, 12-HETE, which
is still rising at 72 h, and is described to induce
fibroblast chemotaxis (46).
In summary, we have observed overlapping phases in
lipid mediator profile during the sunburn response,
from mainly COX-derived proinflammatory products
in the early stages, to predominantly LOX products
during the leukocyte infiltration phases and resolution
phase, in association with UVB up-regulation of COX-2
and 12- and 15-LOX expression (Scheme 2). This study
supports involvement of a specific pattern of eicosanoid
products in this self-limiting inflammatory reaction.
While both n-3 and n-6 PUFA-derived prostanoids are
elevated and may contribute to the vasodilatation re-
sponse, 8-HETE, 11-HETE, and 12-HETE are candidate
mediators of UVB-induced leukocyte chemoattraction.
Our findings of an elevation of the anti-inflammatory
metabolite 15-HETE in the later stages of this response
warrants further examination of its potential role in
resolving the inflammation. A robust resolution re-
sponse may be important in protection against patho-
logical states linked with sunburn, namely skin cancer
and types of photosensitivity.
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